About Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome is a rare disease catalogued by Orphanet (ORPHA:83473). It is associated with the PIK3R2, CCND2, AKT3 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome trials.
Search ClinicalTrials.gov for "Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome" or filter by Orphanet code ORPHA:83473 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome. Updated daily.